Even people who initiate AOMs later, ages 65-74, gain almost six months of additional life, on average, and shrink their average time with diabetes by three-quarters of a year
503A compounding is subject to state pharmacy board oversight and USP sterility standards for injectable preparations, but it is not subject to the FDA's drug approval process, pre-market review, or post-market surveillance requirements that apply to branded pharmaceutical products
However, Saxenda has the limitation of having to self-administer it every day, forcing Novo Nordisk to develop an upgraded medicine with less administrative frequency with enhanced effects
This peptide can improve collagen synthesis and elastin formation, improving skin elasticity, skin texture and sensitive skin, reducing the primary causes of skin aging